DJIA 16,880.36 -31.75 -0.19%
NASDAQ 4,462.90 20.20 0.45%
S&P 500 1,970.07 0.12 0.01%
market minute promo

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

CRTX 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.00

Sector

Healthcare

Industry

Drugs

Cornerstone Therapeutics Inc. (CRTX) Description

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response. Website: http://www.crtx.com/

News & Commentary

Top Insider Trades: PSX YRCW CRTX IDIX

Insider Trading: Marc Lasry Boosts Stake in YRC Worldwide, Baupost Group Increases Idenix Holdings

Plus, a purchase at Cornerstone Therapeutics.

Cornerstone Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript

Osiris Shares Continue to Gain - Analyst Blog

Cornerstone Therapeutics Is Selling Itself Too Cheap

Cornerstone Therapeutics Is Selling Itself Too Short

What's Behind This Biotech's 40% Pop?

Shares of Discovery Labs jumped almost 40% on Friday. Find out what it means for the company as well as drug giant AbbVie and fellow specialty biotech Cornerstone Therapeutics.

Zacks #1 Rank Additions for Wednesday - Tale of the Tape

Law Firm Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduci

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cornerstone Therape

See More CRTX News...

CRTX's Top Competitors

CRTX 0.00 (0.00%)
Current stock: CRTX
AMGN $130.01 (5.43%)
Current stock: AMGN
GILD $93.79 (0.86%)
Current stock: GILD
BIIB $344.52 (0.82%)
Current stock: BIIB